122 related articles for article (PubMed ID: 18766253)
21. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
[TBL] [Abstract][Full Text] [Related]
22. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
23. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.
Ooi EM; Watts GF; Barrett PH; Chan DC; Clifton PM; Ji J; Nestel PJ
Asia Pac J Clin Nutr; 2007; 16(4):624-31. PubMed ID: 18042521
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.
Flote VG; Vettukattil R; Bathen TF; Egeland T; McTiernan A; Frydenberg H; Husøy A; Finstad SE; Lømo J; Garred Ø; Schlichting E; Wist EA; Thune I
Lipids Health Dis; 2016 Mar; 15():56. PubMed ID: 26970778
[TBL] [Abstract][Full Text] [Related]
25. Brazil nut ingestion increased plasma selenium but had minimal effects on lipids, apolipoproteins, and high-density lipoprotein function in human subjects.
Strunz CC; Oliveira TV; Vinagre JC; Lima A; Cozzolino S; Maranhão RC
Nutr Res; 2008 Mar; 28(3):151-5. PubMed ID: 19083402
[TBL] [Abstract][Full Text] [Related]
26. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
[TBL] [Abstract][Full Text] [Related]
27. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
[TBL] [Abstract][Full Text] [Related]
28. Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system.
Ripollés Piquer B; Nazih H; Bourreille A; Segain JP; Huvelin JM; Galmiche JP; Bard JM
Metabolism; 2006 Jul; 55(7):980-8. PubMed ID: 16784973
[TBL] [Abstract][Full Text] [Related]
29. Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins.
Tedeschi-Reiner E; Reiner Z; Sonicki Z
Croat Med J; 2004 Jun; 45(3):333-7. PubMed ID: 15185429
[TBL] [Abstract][Full Text] [Related]
30. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
Fu ZF; Liu ML
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
[TBL] [Abstract][Full Text] [Related]
31. Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.
Tascilar N; Dursun A; Ankarali H; Mungan G; Sumbuloglu V; Ekem S; Bozdogan S; Baris S; Aciman E; Cabuk F
J Neurol Sci; 2009 Feb; 277(1-2):17-21. PubMed ID: 18945448
[TBL] [Abstract][Full Text] [Related]
32. Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS).
Holme I; Aastveit AH; Hammar N; Jungner I; Walldius G
J Intern Med; 2009 Feb; 265(2):275-87. PubMed ID: 19019184
[TBL] [Abstract][Full Text] [Related]
33. Fibrinogen, factor VII, antithrombin III, cholesterol and triglycerides in young men with myocardial infarction and in their sons.
Jastrzebska M; Torbus-Lisiecka B; Pieczul-Mróz J; Chełstowski K; Naruszewicz M
Mater Med Pol; 1997; 29(1-4):3-7. PubMed ID: 10214462
[TBL] [Abstract][Full Text] [Related]
34. Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.
Pownall HJ; Hosken BD; Gillard BK; Higgins CL; Lin HY; Massey JB
Biochemistry; 2007 Jun; 46(25):7449-59. PubMed ID: 17530866
[TBL] [Abstract][Full Text] [Related]
35. Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate.
Taskinen MR; Sullivan DR; Ehnholm C; Whiting M; Zannino D; Simes RJ; Keech AC; Barter PJ;
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):950-5. PubMed ID: 19325138
[TBL] [Abstract][Full Text] [Related]
36. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP.
Lee DM; Alaupovic P; Knight-Gibson C; Bagdade JD
Eur J Clin Invest; 2008 Oct; 38(10):734-42. PubMed ID: 18761668
[TBL] [Abstract][Full Text] [Related]
38. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
[TBL] [Abstract][Full Text] [Related]
39. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
Birjmohun RS; Kees Hovingh G; Stroes ES; Hofstra JJ; Dallinga-Thie GM; Meijers JC; Kastelein JJ; Levi M
Clin Ther; 2008 Dec; 30(12):2314-23. PubMed ID: 19167590
[TBL] [Abstract][Full Text] [Related]
40. Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia.
Allayee H; Castellani LW; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2003 Jun; 92(11):1262-7. PubMed ID: 12738753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
